Quality You Can Trust

We help ensure your biologics, gene therapies, and cell therapies meet global standards.

GLOBAL QUALITY STANDARDS

EU, FDA & ICH-aligned quality systems

cGMP QUALITY OVERSIGHT

Integrated QA across development and manufacturing

QC & RELEASE TESTING

Product-specific testing across multiple modalities

STABILITY PROGRAMS

ICH-aligned stability studies and lifecycle support

ROBUST QUALITY SYSTEMS

Quality management across sites and programs

CMC REGULATORY SUPPORT

Documentation supporting global regulatory submissions

Quality integrated from development to cGMP

Quality is integrated throughout our development and manufacturing environment. Our Quality Assurance, Quality Control, analytical, manufacturing, and regulatory teams work together to support consistent execution and maintain appropriate control as programs progress toward cGMP manufacturing.

Across biologics, gene therapy, and cell therapy, we apply quality strategies aligned with the product, process, development stage, and applicable regulatory requirements.

Quality Assurance

Quality built into every stage

Our Quality Assurance organization provides oversight across development, technology transfer, cGMP manufacturing, testing, and release. A robust quality management system provides the framework for consistent execution, documentation, compliance, and product quality.

Quality oversight is integrated with technical and operational teams throughout the program, supporting efficient progression from development into cGMP manufacturing.

Core capabilities

  • GMP quality oversight
  • Quality management systems
  • Deviation, CAPA, and change control management
  • Internal and external audits
  • Supplier and material quality oversight
  • Documentation and data integrity
  • Batch record review and disposition
  • Training and quality compliance
  • Regulatory inspection and client audit support

Quality Control

 

Product-specific QC from manufacturing through release

Our Quality Control capabilities support in-process, drug substance, drug product, stability, and release testing across biologics, gene therapy, and cell therapy programs.

Testing strategies are tailored to the product and development stage, combining physicochemical, biochemical, molecular, microbiological, and biological methods as appropriate. Close integration with analytical development and manufacturing supports method transfer, specifications, stability programs, and cGMP release.

 

Biologics

Quality control for recombinant proteins, monoclonal and multispecific antibodies, fusion proteins, and other complex biologics, supporting relevant quality attributes including identity, purity, potency, product-related variants, and process-related impurities.

 

Gene Therapy

Product-specific QC strategies for plasmid DNA and viral vector programs, incorporating molecular, physicochemical, microbiological, and biological methods to support assessment of identity, purity, potency, safety, and other relevant quality attributes.

 

Cell Therapy

Quality control strategies tailored to the cellular product and manufacturing process, supporting relevant critical quality attributes including identity, viability, purity, potency, and safety.

Process & capabilities

  • Quality control oversight
  • Specifications, SOPs, and testing execution
  • Analytical method validation (ICH)
  • QC testing across materials and products
  • Reference standards and sample management
  • Stability program management
  • Environmental monitoring
  • Analytical support for validation

Stability Programs

Supporting product stability throughout development

We design and execute stability programs to support product understanding, establish appropriate storage conditions and shelf life, and generate data for regulatory submissions.

Stability activities can be integrated with development, manufacturing, analytical, QC, and regulatory functions, providing continuity as programs advance.

Core capabilities

  • ICH-aligned stability programs
  • Drug substance and drug product stability
  • Long-term and accelerated studies
  • In-use and supporting stability studies, as applicable
  • Stability-indicating analytical methods
  • Data trending and evaluation
  • Shelf-life support
  • Stability documentation for regulatory submissions

Regulatory & CMC Support

 

Connecting technical development with regulatory strategy

Our Regulatory Affairs team works alongside development, analytical, manufacturing, and quality teams to support preparation and review of CMC documentation for global regulatory submissions.

This integrated approach helps ensure that process, analytical, manufacturing, and quality information is brought together into clear, consistent, and submission-ready CMC documentation.

Core capabilities

  • CMC documentation supporting INDs and IMPDs
  • Module 3 preparation and review
  • CMC support for BLAs and MAAs, as applicable
  • Manufacturing, analytical, and quality documentation review
  • Submission content review for consistency and completeness
  • Responses to CMC-related regulatory questions
  • Post-submission and lifecycle documentation support
  • Regulatory support across biologics and advanced therapies

Frequently asked questions

Can you support my product from development to commercialization?

Yes, we provide end-to-end support, covering development, clinical manufacturing, regulatory submissions, and lifecycle management.

Our teams ensure accurate documentation, thorough testing, and compliance with global requirements, helping streamline submissions and avoid delays.

By combining QA, QC, and Regulatory Affairs in-house, we ensure better coordination, faster issue resolution, and a more efficient path to market.

We prepare and review CMC documentation for INDs, IMPDs, BLAs, and MAAs, ensuring submissions are complete, consistent, and aligned with regulatory requirements.

We continuously update our processes in line with emerging regulatory requirements, maintain audit readiness, and apply ongoing training and quality system improvements to ensure long-term compliance.

Resources